| Document Date: 2015-04-22 13:36:51
Open Document File Size: 162,46 KBShare Result on Facebook
City Houston / New York / Yavne / Bethlehem / / Company Pfizer / GlaxoSmithKline / Merck / Celldex Therapeutics / Abraxis BioScience / Sony / Celgene / AstraZeneca / Bristol-Myers Squibb / Bristol-Myers Squibb Co. / / Country United States / Israel / / Currency USD / / Event FDA Phase / M&A / Business Partnership / / Facility MD Anderson Cancer Center / Memorial Sloan Kettering / Luke's University Hospital / / MedicalCondition III disease / III melanoma / solid tumors / melanoma / liver cancer / breast cancer / / MedicalTreatment chemo / neoadjuvant therapy / chemotherapy / surgery / immunotherapy / / Organization St. Luke's University Hospital / European Union / / Person Peter Culpepper / / Position Governor / CFO / / Product US / PV-10 / / ProvinceOrState Texas / Pennsylvania / / Technology Biopharmaceuticals / antibodies / /
SocialTag |
Provectus prioritizes pharma partners with clinical-stage PD1/PDL1s – exec - UPDATE By Sony Salzman [Subsequent to publication, this news service learned that Provectus was open to